2m 2m 2m 2m 2m 2m 2m
SAGIMET BIOSCN-A (SGMT)
NASDAQ
$11.19+$0.30 (+2.76%)
Price as of Nov 11, 2026 7:35 PM EST- $766.0MMarket Cap
- 28.12%1-Year Change
- BiotechnologyIndustry
SAGIMET BIOSCN-A (SGMT)
$11.19+$0.30 (+2.76%)
SGMT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.89 | ||
Change | +$0.06 (+0.55%) | ||
Open | $10.66 | ||
High | $11.01 | ||
Low | $10.48 | ||
Previous Close | $10.83 | ||
Volume | 1,573,274 | ||
30-Day Average Volume | 1,223,800 | ||
1-Week Change | 9.45% | ||
1-Month Change | 21.95% | ||
1-Year Change | 28.12% | ||
3-Year Change | 321.28% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 70.3M | ||
Total Assets | $263.4M | ||
Market Cap | $766.0M | ||
Enterprise Value | $600.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$14.0M | ||
Free Cash Flow | -$11.1M | ||
EBIT | -$14.0M | ||
EBITDA | -$14.0M | ||
Net Working Capital | $238.6M | ||
EPS | -$0.26 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -42 | ||
PEG | -2 | ||
Price/Free Cash Flow | -69 | ||
Price/Operating Cash Flow | -69 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue